Alibaba Health Informatio... (ALBHF)
OTC: ALBHF
· Real-Time Price · USD
0.67
0.01 (1.89%)
At close: Aug 15, 2025, 9:30 AM
0.66
-1.79%
After-hours: Aug 13, 2025, 08:00 PM EDT
Alibaba Health Information Technology Income Statement
Financials in CNY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
Revenue | 8.16B | 8.16B | 7.14B | 7.14B | 14.07B | 7.04B | 12.96B | 15.26B | 11.5B | 11.22B | 9.36B | 8.36B | 7.16B |
Cost of Revenue | 6.21B | 6.21B | 5.37B | 5.37B | 11.04B | 5.52B | 10.09B | 11.86B | 9.2B | 8.98B | 7.49B | 6.6B | 5.31B |
Gross Profit | 1.95B | 1.95B | 1.77B | 1.77B | 3.03B | 1.51B | 2.87B | 3.4B | 2.3B | 2.24B | 1.87B | 1.76B | 1.86B |
Operating Income | 346.57M | 346.57M | 392.69M | 392.69M | 378.54M | 189.27M | 260.08M | -13.38M | -38.13M | -507.33M | -591.1M | -184.64M | 222.11M |
Interest Income | n/a | n/a | n/a | n/a | 294.7M | n/a | 201.86M | 182.61M | 143.14M | 120.29M | 89.47M | 101.97M | 62.36M |
Pretax Income | 369.45M | 369.45M | 410.53M | 410.53M | 458.13M | 229.06M | 481.27M | 377.02M | 173.97M | -22.65M | -229.86M | 76.78M | 324.44M |
Net Income | 331.74M | 331.74M | 384.48M | 384.48M | 437.59M | 218.79M | 445.89M | 373.46M | 162.19M | -33.78M | -231.77M | 65.16M | 283.43M |
Selling & General & Admin | 1.4B | 1.4B | 1.21B | 1.21B | 2.26B | 1.13B | 2.29B | 3.05B | 2.01B | 2.34B | 2.13B | 1.73B | 1.4B |
Research & Development | 200.42M | 200.42M | 159.61M | 159.61M | 386.07M | 193.03M | 319.31M | 353.84M | 323.99M | 406.08M | 322.75M | 194.18M | 229.45M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.6B | 1.6B | 1.37B | 1.37B | 2.65B | 1.32B | 2.59B | 3.21B | 2.27B | 2.38B | 2.19B | 1.79B | 1.59B |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 638.84M | 638.84M | 490.35M | 490.35M | 907.19M | 453.59M | 869.38M | 909.78M | 858.89M | 997.57M | 983.71M | 713.27M | 508.74M |
Cost & Expenses | 7.82B | 7.82B | 6.74B | 6.74B | 13.69B | 6.85B | 12.68B | 15.07B | 11.47B | 11.36B | 9.68B | 8.38B | 6.9B |
Income Tax Expense | 37.97M | 37.97M | 26.01M | 26.01M | 20.14M | 10.07M | 36.13M | 4.02M | 10.47M | 11.72M | 1.71M | 12.65M | 45.89M |
Shares Outstanding (Basic) | 16.18B | 16.18B | 16.09B | 16.09B | 14.63B | 14.63B | 13.55B | 13.54B | 13.52B | 13.49B | 13.48B | 13.45B | 13.12B |
Shares Outstanding (Diluted) | 16.18B | 16.18B | 16.1B | 16.1B | 14.63B | 14.63B | 13.55B | 13.56B | 13.52B | 13.49B | 13.48B | 13.53B | 13.12B |
EPS (Basic) | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 | 0.03 | 0.03 | 0.01 | -0.00 | -0.02 | 0.00 | 0.02 |
EPS (Diluted) | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 | 0.03 | 0.03 | 0.01 | -0.00 | -0.02 | 0.00 | 0.02 |
EBITDA | 350.02M | 350.02M | 392.85M | 392.85M | 389.04M | 193.27M | 272.2M | -575K | -23.9M | -490.97M | -585.58M | -175.62M | 227.76M |
EBIT | 340.59M | 340.59M | 386.22M | 386.22M | 377.27M | 187.39M | 260.08M | -13.38M | -38.13M | -507.33M | -591.1M | -184.64M | 222.11M |
Depreciation & Amortization | 9.44M | 9.44M | 6.63M | 6.63M | 11.77M | 5.88M | 12.12M | 12.8M | 14.22M | 16.36M | 5.52M | 9.02M | 5.65M |